chr8-7056649-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021010.3(DEFA5):c.49G>T(p.Ala17Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,613,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_021010.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DEFA5 | NM_021010.3 | c.49G>T | p.Ala17Ser | missense_variant | 1/2 | ENST00000330590.4 | NP_066290.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEFA5 | ENST00000330590.4 | c.49G>T | p.Ala17Ser | missense_variant | 1/2 | 1 | NM_021010.3 | ENSP00000329890.2 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152186Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000915 AC: 23AN: 251376Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135846
GnomAD4 exome AF: 0.0000369 AC: 54AN: 1461552Hom.: 0 Cov.: 31 AF XY: 0.0000316 AC XY: 23AN XY: 727070
GnomAD4 genome AF: 0.000302 AC: 46AN: 152304Hom.: 0 Cov.: 33 AF XY: 0.000295 AC XY: 22AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 27, 2024 | The c.49G>T (p.A17S) alteration is located in exon 1 (coding exon 1) of the DEFA5 gene. This alteration results from a G to T substitution at nucleotide position 49, causing the alanine (A) at amino acid position 17 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at